Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Autoimmune Disease Diagnosis Market Growth Performance Trended Historically, And What Lies Ahead?

In recent times, there has been a notable expansion in the market size for diagnosing autoimmune diseases. It is forecasted to rise from $5.84 billion in 2024 to approximately $6.2 billion in 2025, experiencing a compound annual growth rate (CAGR) of 6.2%. The historical growth within this sector can be accredited to escalating occurrences of autoimmune diseases, the evolution of emerging markets, a surge in healthcare spending, and the heightened prevalence of these diseases in women.

The market size of autoimmune disease diagnosis is predicted to witness significant expansion in the coming years, reaching a valuation of$8.65 billion by 2029, with a compound annual growth rate (CAGR) of 8.7%. The anticipated surge during the forecast period can be traced back to factors such as heightened investments in AI diagnostics, robust economic progress, growing cognizance about autoimmune maladies, and biomarker identification. Key market trends projected for this period include forming partnerships with other market leaders, funding artificial intelligence startups, collaboration with government entities, and the production of rapid at-home testing kits.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3231&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Autoimmune Disease Diagnosis Market?

The upswing in autoimmune diseases is a significant factor propelling the expansion of the autoimmune disease diagnosis market. Drawing from data provided by Multiple Sclerosis Australia, a non-profit organization committed to research and advocacy for victims of multiple sclerosis, it was reported in February 2023 that the number of Multiple Sclerosis patients in Australia had escalated to 33,335 in 2021. This figure represents a 30% (7,728) increase from the previous tally of 25,607 over the last four years. Consequently, the global upsurge in autoimmune disease incidence is fuelling the growth of the autoimmune disease diagnosis market.

Which Key Market Segments Comprise the Autoimmune Disease Diagnosis Market and Drive Its Revenue Growth?

The autoimmune disease diagnosismarket covered in this report is segmented –

1) By Product: Consumables And Assay Kits, Instruments

2) By End User: Clinical Laboratories, Hospitals, Others

3) By Test Type: Routine Laboratory Tests, Autoantibodies Tests, Immunologic Tests, Other Tests

Subsegments:

1) By Consumables And Assay Kits: ELISA Kits; Reagents And Test Kits; Sample Collection And Preservation Devices; Control And Calibration Materials

2) By Instruments: Immunoassay Analyzers; Flow Cytometers; Luminometers; Microscopes; Other Diagnostic Devices

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=3231&type=smp

Which Areas Are Leading Regions in the Autoimmune Disease Diagnosis Market Expansion Across the Globe?

North America was the largest region in the autoimmune disease diagnosis market in 2024. Western Europe was the second largest region in the autoimmune disease diagnosis market share. The regions covered in the autoimmune disease diagnosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Strategic Trends Steering theAutoimmune Disease Diagnosis Market Direction?

In the autoimmune disease diagnosis market, biosensors and nano biosensors for swift detection serve as innovative tools for identifying antibodies. These are heavily favored due to their affordability, heightened sensitivity, user-friendly nature, multiplexing capabilities, and speedy diagnosis. Aside from measuring antibody count in the human blood serum with remarkable precision, these tools also gauge antibody activity, as they utilize portable optical label-free biosensors that operate on the principles of spectral correlation interferometry. This point-of-care technology proves to be more comprehensive, insightful, prompt, and accurate in diagnosing autoimmune diseases in comparison to traditional methods.

View the full report here:

https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report

How Is the Autoimmune Disease Diagnosis Market Conceptually Defined?

Autoimmune disease diagnosis refers to the diagnosis of diseases in which the production of antibodies takes place in the body which attacks and destroys healthy cells in the body. These include Crohn’s disease, rheumatoid arthritis, Hashimoto’s disease, multiple sclerosis, Grave’s disease, psoriasis, coeliac disease, type 1 diabetes, lupus, and inflammatory bowel syndrome, and are diagnosed by immunological tests.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3231

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model